So, you just grew your Amazon business to surpass the $10 million mark and you are looking at other points of distribution. A colleague or investor suggests that you launch in Target. It sounds like a great idea.
and their brand partners — to stop “trying harder” and start “trying differently.
The year is not starting with a bang, but with a slow and uncertain step forward. Inflation is still rising; the threat of a recession looms on the horizon.
Is a regulatory reckoning just around the corner for vitamins, minerals, herbals and supplements? The more my partners and I at the New England Consulting group look at some of NIH’s (National Institutes of Health’s) recent programming and FTC’s (Federal Trade Commission’s) enforcement actions since
One of the key insights coming out of our latest How America Shops research is how much people’s trust has been eroded over the last several years. I suppose that shouldn’t be a surprise in this day and age when the world is in such turmoil. However, we can’t only blame politicians and bankers and
The National Association of Chain Drug Stores is about to convene its Annual Meeting, that laudable and impressive gathering of mass retailers and suppliers that highlights every spring.
Amazon has put another building block in place as it works to bring the experience of pharmacy customers fully into the digital era.
The dispensing of mifepristone, one of two medications used sequentially to terminate pregnancy, has emerged as a very thorny problem for Walgreens, one that will, in short order, engulf other retail pharmacies across the country.
and not under the most favorable circumstances. Along with other newspapers and periodicals, The New York Times has lately put Walgreens in its cross hairs, with attention-grabbing headlines such as these:
Prescription drug discount cards are a fast-growing market. The growing complexity of insurance plans and a system of pharmaceutical discounts and rebates that is not visible to the patient have widened the discrepancy between the cost of drugs and what patients actually pay.
CVS Health’s long anticipated push into primary care represents yet another milestone for the company, which in little more than three decades has transformed itself from a regional drug chain into one of the nation’s leading multifaceted health care providers, as well as a potential turning point i
Imagine, if you can, a drug store without a pharmacy. Once upon a not-so-distant time, many chain drug stores opened without pharmacies, calling themselves health and beauty aid stores.
At-home diagnostic testing has grown from a nascent pre-pandemic trend to an emerging, high-growth health product category in the pandemic’s wake. The accelerated adoption of over-the-counter COVID-19 rapid antigen tests used for at-home self-testing was the tipping point.
By now it has become a familiar refrain: Amazon is taking another step to extend its reach in the $4 trillion health care sector.
The new year has been under way for about a month now, and speculation about the upcoming 12 months already abounds. Not to be left at the starting gate, here’s a look from Chain Drug Review’s headquarters into what just might happen between now and December 31 and what will remain anyone’s guess.
How could an economic downturn in 2023 impact the most vulnerable patients? If we look at lessons from past recessions, we see that increases in unemployment, inflation and financial stress significantly impact access to medicines.
